News & Updates

Filter By:
All
News
Press Releases
Events
Videos
Publications

News | Press Releases

InCarda Therapeutics Provides Corporate Update Highlighting New Phase 2 Data for InRhythm™ Program, Plans for Pivotal Phase 3 Study and Expansion of Senior Management Team

Read More

News

InCarda CEO Grace Colón Elected to the Board of the MIT Corporation

Read More

Events

Grace Colón Participates on Panel Hosted by Women in Bio (WIB)

Read More

Events | News

Grace Colón Participates in virtual workshop “Innovation in Drug Research and Development for Prevalent Chronic Diseases”

Read More

News

InCarda Therapeutics featured in Men’s Health

Read More

News | Press Releases

InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of InRhythm™ for Treatment of Atrial Fibrillation

Read More

Events | News

InCarda’s CEO Grace Colon participated in a panel discussion at Biotech Showcase 2021 on January 11, 2021

Read More

News

Grace Colón Joins the First Rounders Podcast

Read More

Events | News

Grace Colón & Jeff Ho Join FIRESIDE chat with Umer Raffat & Michael DiFiore

Read More

Events | News

InCarda Therapeutics to Present Preliminary Phase 2 Data at American Heart Association 2020 Scientific Sessions (Nov. 13-17, 2020)

Read More

Press Releases

InCarda Therapeutics Presents Positive New Data from Phase 2 Study of InRhythm™ in Patients with Paroxysmal Atrial Fibrillation at American Heart Association Scientific Sessions 2020

Read More

News

InCarda Therapeutics featured in Endpoints News

Read More

Tweets by InCardaThera

Clinical Announcement

InCarda Therapeutics Recruiting for Phase 2 Clinical Trial in PAF

Read More